Dr. Getinet Mequanint Adinew is a biomedical scientist with expertise in pharmacology, toxicology, and drug development. He holds a Ph.D. in Pharmaceutical Sciences and is currently a postdoctoral research fellow at Duke University. His work focuses on the pharmacological evaluation of novel therapeutic agents, including anticancer compounds and drug delivery systems, using both in vitro and in vivo models to assess efficacy and safety. Dr. Adinew has contributed to several peer-reviewed publications and research projects in cancer pharmacology, and GPCR signaling, His research emphasizes translational approaches aimed at bridging laboratory discoveries with clinical applications. In addition to research, he is actively involved in peer reviewing scientific manuscripts, bringing a strong sense of rigor, clarity, and integrity to the evaluation process. He has also taught pharmacology and toxicology and has mentored students in laboratory techniques, data analysis, and scientific communication. Dr. Adinew is passionate about advancing biomedical science through collaboration, education, and critical scientific review. His multidisciplinary training and commitment to research excellence position him to contribute effectively in academic, research, review, and editorial roles.